A detailed history of Allspring Global Investments Holdings, LLC transactions in Vericel Corp stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 404,861 shares of VCEL stock, worth $22.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
404,861
Previous 420,643 3.75%
Holding current value
$22.9 Million
Previous $19.3 Million 11.37%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$42.25 - $53.56 $666,789 - $845,283
-15,782 Reduced 3.75%
404,861 $17.1 Million
Q2 2024

Jul 26, 2024

BUY
$41.71 - $52.9 $1.07 Million - $1.36 Million
25,626 Added 6.49%
420,643 $19.3 Million
Q1 2024

Apr 18, 2024

SELL
$32.52 - $52.33 $1.37 Million - $2.21 Million
-42,221 Reduced 9.66%
395,017 $20.5 Million
Q4 2023

Jan 25, 2024

SELL
$30.85 - $37.09 $3.18 Million - $3.82 Million
-102,971 Reduced 19.06%
437,238 $15.6 Million
Q3 2023

Oct 27, 2023

BUY
$31.69 - $39.25 $17.1 Million - $21.2 Million
540,209 New
540,209 $18.1 Million
Q2 2023

Jul 18, 2023

BUY
$29.0 - $38.37 $7.17 Million - $9.49 Million
247,268 Added 163.26%
398,721 $15 Million
Q1 2023

Apr 13, 2023

SELL
$23.85 - $31.34 $233,300 - $306,567
-9,782 Reduced 6.07%
151,453 $4.44 Million
Q4 2022

Jan 23, 2023

SELL
$17.65 - $27.37 $4.69 Million - $7.28 Million
-265,936 Reduced 62.26%
161,235 $4.25 Billion
Q3 2022

Oct 26, 2022

SELL
$22.62 - $32.54 $12 Million - $17.2 Million
-528,512 Reduced 55.3%
427,171 $9.91 Million
Q2 2022

Jul 25, 2022

SELL
$22.88 - $39.45 $815,008 - $1.41 Million
-35,621 Reduced 3.59%
955,683 $24.1 Million
Q1 2022

May 02, 2022

SELL
$31.69 - $43.29 $170,492 - $232,900
-5,380 Reduced 0.54%
991,304 $37.9 Million
Q4 2021

Jan 28, 2022

BUY
$35.2 - $52.6 $35.1 Million - $52.4 Million
996,684 New
996,684 $39.2 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.